Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,560.00
Bid: 3,560.00
Ask: 3,565.00
Change: 10.00 (0.28%)
Spread: 5.00 (0.14%)
Open: 3,520.00
High: 3,570.00
Low: 3,520.00
Prev. Close: 3,550.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited net asset value and portfolio update

8 Jan 2024 07:00

RNS Number : 8590Y
Caledonia Investments PLC
08 January 2024
 

Caledonia Investments plc

 

Unaudited net asset value and portfolio update

 

Caledonia Investments plc ("Caledonia") announces that its unaudited diluted net asset value per share ("NAV") as at 31 December 2023, calculated on a cum-income basis, was 5180p.

 

The NAV total return ("NAVTR") for the nine months to 31 December 2023 was 3.6%. A final dividend of 49.2p per ordinary share for the year ended 31 March 2023 was paid to shareholders on 3 August 2023 and an interim dividend of 18.93p per ordinary share for the current year was paid on 4 January 2024, amounting to payments of £26.7m and £10.3m respectively.

 

This announcement provides a further update on Caledonia's portfolio and should be read in conjunction with the factsheet dated 31 December 2023 and released on 8 January 2024, a copy of which is available at www.caledonia.com.

 

Summary

 

All three pools generated positive returns during the first nine months of the year. This positive performance was despite the adverse impact of Sterling strengthening against the US dollar in the period.

 

The Public Companies pool produced a return of 6.8%, reflecting strong performance of a number of our holdings offset by the adverse foreign exchange movement. The Private Capital portfolio produced a return of 6.1%, following good performance from the majority of the investee companies and the contractually agreed disposal of Seven Investment Management ("7IM"). The 7IM transaction is expected to complete in January 2024, with anticipated cash proceeds of c.£255m. The Funds pool returned 1.0% in the period, driven by valuation growth of our North American funds, offset by adverse foreign exchange movements. As previously reported, there has been a notable slowdown in the level of fund distributions over the nine month period reflecting reduced market transaction activity. Based on feedback from fund managers, an improvement in distributions is anticipated over the next six to eighteen months.

 

Performance for the nine month period to 31 December 2023 is summarised in the table below.

 

Caledonia pool performance

Net asset value - nine months to 31 December 2023 

 

£m

 

 

NAV

31/3/23

Net

investment

/(disposal)

Capital

gains /

(losses)

Other

NAV

31/12/23

Income

Total

Return

Public Companies

836.9

33.6

39.4

-

909.9

17.7

6.8%

Private Capital

824.0

159.3

37.6

3.0

1,023.9

20.2

6.1%

Funds

873.8

59.0

5.5

-

938.3

3.8

1.0%

Portfolio

2,534.7

251.9

82.5

3.0

2,872.1

41.7

Net Cash/(Debt)

221.6

(251.9)

-

(23.5)

(53.8)

Other assets

41.7

-

-

3.5

45.2

Net assets

2,798.0

 

-

82.5

(17.0)

 

2,863.5

NAVTR

3.6%

 

Caledonia has continued to invest and dispose of assets, in line with our active approach to portfolio management.

 

The movement in net debt in nine month period was £275m, largely reflecting net investments made by all three pools and, most significantly, the acquisition of a majority stake in the European division of AIR-serv in April 2023 by Private Capital. The Public Companies pool made additions to its holdings in three companies, refined positions in a number of others and reduced positions in two high performing stocks, creating a net investment outflow of £34m. The Funds pool net cash outflow was £55m in the period.

 

Net debt at 31 December 2023 is £54m. Total liquidity of £196m remains healthy and will increase following the receipt of 7IM sales proceeds of c.£255m in January 2024. The £250m revolving credit facilities include £137.5m expiring in November 2027, with the balance of £112.5m expiring in July 2025.

 

Caledonia Public Companies - Capital and Income portfolios (32% of NAV)

 

The total return of the Public Companies pool was 6.8% over the first nine months of the year. This outcome reflected strong performance of a number of our holdings offset by the adverse foreign exchange movement.

 

The Capital portfolio delivered a return of 8.4%. Key performance contributors included Hill & Smith, Microsoft, Oracle and Watsco, which delivered very strong returns ranging from 15% to 45%. However, these gains were partially offset by negative contribution from companies including Alibaba, Croda International and Thermo Fisher Scientific.

 

The Income portfolio generated a return of 2.3%. Strong returns from Watsco, RELX (a new position in the portfolio), Sabre and Fastenal were offset by weaker share price performances from Diageo, Reckitt, BAT and Texas Instruments.

 

Trading activity remained targeted and opportunistic, in line with our long-term investment approach, with increases in our holdings including Croda International, Spirax Sarco, Symrise as well as the new position in RELX. We sold down a portion of our holdings in Microsoft, Oracle and Watsco, following a period of strong share price appreciation. In addition, the Income portfolio moved closer to its target of £250m of invested cost.

 

Caledonia Private Capital (35% of NAV)

 

Caledonia's Private Capital portfolio is dominated by significant positions in five UK-centric businesses and one private European investment company. These six investments represent over 90% of the pool's value. Investee companies are revalued in March and September each year. The portfolio generated a total return of 6.1% in the nine-month period.

The five UK centric businesses are well-established and have strong market positions. Of these five businesses four, excluding 7IM, are valued on an earnings multiple basis, with multiples in the range 9 to 14 times current year earnings. Gearing levels are modest, with net debt of approximately 2 to 3 times earnings before interest, tax, depreciation and amortisation ("EBITDA"). 

In early September 2023, Caledonia announced the agreed sale of a majority stake in 7IM, a vertically integrated retail wealth management business, to Ontario Teachers' Pension Plan Board. The transaction is expected to complete in January 2024, with cash proceeds of c.£255m (net of transaction expenses) expected. The valuation at the end of December of £249m, reflects expected cash proceeds less a 3% discount to equity value in recognition of the very limited degree of transaction execution risk.

 

Cobepa, the Belgian based investment company, owns a diverse portfolio of private global investments. The majority of the businesses within the Cobepa portfolio continue to develop well, with many delivering strong performance and valuation progression.

Stonehage Fleming, the international multi-family office, continues to deliver good revenue and margin growth across each of the Family Office, Investment Management and Financial Services businesses, driven by client wins and increased activity levels.

AIR-serv Europe, a leading designer and manufacturer of air, vacuum and jet wash machines, which it provides to fuel station forecourt operators across the UK and Western Europe, was acquired in April 2023. The business is trading ahead of expectations, demonstrating good year on year growth. In September 2023 the valuation was maintained at the equity purchase cost of £143m. The position will be reviewed in March 2024 in line with our valuation policy.

Liberation Group, an inns and drinks business with a pub estate stretching from Southwest London to Bristol and the Channel Islands, continues to deliver strong revenue growth and improving profitability. The integration of the Cirrus Inns business, acquired in December 2022, is progressing well and now largely complete.

 

Cooke Optics, a leading manufacturer of cinematography lenses, has been heavily impacted by the Hollywood writers' strike which started in early May 2023 and the subsequent actors' strike. With both disputes now resolved, demand for the company's products is recovering. The valuation as at 30 September 2023, reflected a 15% equity discount to reflect this matter. No change has been made to this discount which will be reviewed in March 2024.

 

A more detailed update on the trading and valuation of all investee companies within the Private Capital portfolio will be provided in Caledonia's full year results announcement in May 2024.

 

Caledonia Funds (33% of NAV)

 

The total return on the Funds portfolio was 1.0% for the nine month period, reflecting valuation growth of the North American holdings offset by the 3.1% strengthening in Sterling versus the US Dollar.

 

During the nine month period, £90m was invested and distributions of £35m were received. There has been a notable slow down in the level of distributions, compared to the last two years, reflecting more challenging market conditions. Based on feedback from fund managers, an improvement in distributions is anticipated over the next six to eighteen months.

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

Mat Masters

Chief Executive Officer

 

Rob Memmott

Chief Financial Officer

 

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

8 January 2024

 

Notes

 

Valuation approach and methodology

 

The valuation approach utilised for each asset portfolio is summarised below.

 

Caledonia Public Companies: all listed companies are valued based on the closing bid price on the relevant exchange as at 31 December 2023.

 

Caledonia Private Capital: the holdings are valued biannually, principally on a normalised EBITDA x market multiple basis (in line with the latest IPEV guidelines). This approach was applied to the majority of significant assets in the portfolio on 30 September 2023. The exceptions to this approach were our holdings in Cobehold, where fair value was derived from the external valuation prepared by Cobepa, and 7IM, where the valuation was derived from the contractually agreed disposal announced in early September 2023. In the case of Liberation Group, the earnings derived valuation was supported by the underlying value of the principally freehold pub estate plus the value of the drink production and distribution business.

 

Caledonia Funds: the fund valuations are based on the most recent valuations provided by the fund managers, subject to cash movements from the valuation date. Valuations are received 60 to 180 days from the valuation date.

 

Caledonia Investments plc

 

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. This is achieved by investing in proven, well-managed businesses that combine long-term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBRGDBLSGDGSU
Date   Source Headline
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.